Concourse Financial Group Securities’s NeuroSense Therapeutics Ltd. Warrant NRSNW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 5488 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 6352 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 6346 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 6365 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 6362 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 6293 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 6158 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 6013 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 5796 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 5792 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 5613 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 5590 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 5485 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 5490 |
|